Marketing-authorisation holder · Italy
ANGELINI SpA
9 medicines in 3 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Italy
9 medicines in 3 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Ontozry | Cenobamate | EU (EMA) | Authorised | 2021 |
| Ontozry 100mg, filmomhulde tabletFilmomhulde tablet | Cenobamate | Netherlands | Authorised | 2022 |
| Ontozry 12,5mg, filmomhulde tabletFilmomhulde tablet | Cenobamate | Netherlands | Authorised | 2022 |
| Ontozry 150mg, filmomhulde tabletFilmomhulde tablet | Cenobamate | Netherlands | Authorised | 2022 |
| Ontozry 200mg, filmomhulde tabletFilmomhulde tablet | Cenobamate | Netherlands | Authorised | 2022 |
| Ontozry 25mg, filmomhulde tabletFilmomhulde tablet | Cenobamate | Netherlands | Authorised | 2022 |
| Ontozry 50mg, filmomhulde tabletFilmomhulde tablet | Cenobamate | Netherlands | Authorised | 2022 |
| Trittico 150 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Trazodone | Croatia | Marketed | 2019 |
| Trittico 75 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Trazodone | Croatia | Marketed | 2019 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 6 | 6 | 0 | CompaniesAll medicines |
| Croatia | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Italy
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.